• SMYD2 Inhibition Alleviates Cisplatin-Induced Renal Fibrosis

  2026-06-08

  This study reveals that pharmacological inhibition of SMYD2, using molecules such as LLY-507, significantly reduces renal fibrosis and inflammation in a cisplatin-induced chronic kidney disease (CKD) model. These results highlight SMYD2 as a pivotal regulator in CKD pathogenesis and suggest new strategies for antifibrotic therapies.

• FMO3-TMAO Axis in Aging Adipose Tissue Dysfunction: Mechanis

  2026-06-07

  The referenced study demonstrates that white adipose tissue (WAT) is a previously underappreciated source of TMAO production via FMO3, especially during aging. Adipocyte-specific FMO3 ablation mitigates metabolic dysfunction by reducing inflammation, fibrosis, and senescence in WAT, providing new therapeutic directions for age-related metabolic diseases.

• Efficient RGC Generation from iPSCs via Dual SMAD and Wnt In

  2026-06-06

  This study introduces a chemically defined method using dual SMAD and Wnt pathway inhibition to reproducibly differentiate induced pluripotent stem cells (iPSCs) into highly pure retinal ganglion cells (RGCs). The approach addresses previous challenges of variability and low yield, supporting more reliable glaucoma and neurodegenerative disease modeling.

• NLRP10’s Role in Keratinocyte Survival and Epidermal Barrier

  2026-06-05

  This study establishes NLRP10 as a pivotal regulator of epidermal homeostasis, demonstrating its necessity for keratinocyte survival and p63-dependent differentiation. By clarifying the molecular mechanisms underlying skin barrier dysfunction in atopic dermatitis, the findings highlight NLRP10 as a promising therapeutic target for restoring epidermal integrity.

• Pam3CSK4 TFA: TLR1/2 Agonist for Translational Immunity Rese

  2026-06-05

  Pam3CSK4 TFA empowers researchers with highly reproducible, robust activation of TLR1/2 pathways for dissecting innate immune responses both in vitro and in vivo. Its role in cytokine profiling—especially for maternal-neonatal risk stratification—sets it apart as a cornerstone reagent for translational immunology.

• Circ_0042103/TAF15/NER Axis Drives DNA Damage in Pulpitis

  2026-06-04

  This study elucidates how the circular RNA circ_0042103, by binding TAF15, suppresses nucleotide excision repair (NER) proteins and heightens DNA damage and inflammation in dental pulp stem cells during pulpitis. These findings identify a regulatory circRNA/protein axis pivotal for both inflammation and DNA repair, informing future research on targeted therapies and advanced RNA analysis workflows.

• HyperFluor™ 488 Rabbit Anti-Goat IgG: Elevating Immunoassay

  2026-06-04

  HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody distinguishes itself with robust signal amplification and low cross-reactivity for fluorescence-based immunoassays. Its streamlined protocol and versatility across ICC, IHC, WB, and flow cytometry empower researchers to achieve clear, reproducible results, even in demanding tissue models.

• SNS-032 (BMS-387032): Applied Strategies in Cancer and Viral

  2026-06-03

  SNS-032 (BMS-387032) stands at the intersection of cancer biology and host-targeted antiviral research, offering streamlined protocols for cell cycle and transcriptional regulation studies. Explore proven workflows, troubleshooting guidance, and novel cross-domain applications—anchored by the latest mechanistic insights.

• IgSF6 Deficiency Enhances Macrophage Antibacterial Response

  2026-06-03

  The referenced study uncovers the role of ER-localized immunoglobulin IgSF6 in modulating endoplasmic reticulum stress and the inflammatory response in intestinal macrophages. IgSF6 deficiency heightens macrophage antibacterial capacity by amplifying ER stress and reactive oxygen species production, offering new insight into gut immune regulation and potential therapeutic strategies for infection and inflammatory disease.

• Bifendate (DDB): Deep Dive into CYP3A4 Modulation and Hepati

  2026-06-02

  Explore how Bifendate (DDB) uniquely modulates CYP3A4 and autophagy for advanced hepatoprotection. This article delivers a mechanistic, evidence-driven analysis and practical assay guidance for liver research.

• EdU Imaging Kits (Cy5): Superior S-Phase DNA Synthesis Detec

  2026-06-02

  EdU Imaging Kits (Cy5) revolutionize cell proliferation analysis by combining high-sensitivity S-phase DNA synthesis detection with workflow efficiency. Their click chemistry-based protocol preserves morphology and supports robust genotoxicity and neurodevelopmental research, outperforming traditional BrdU assays.

• Gamithromycin (ML-1709460): Precision PK/PD for Advanced Res

  2026-06-01

  Explore the advanced pharmacokinetics and unique lung-targeting properties of Gamithromycin (ML-1709460) for veterinary respiratory research. This article delivers actionable insights on protocol design, tissue distribution, and evidence-based assay optimization.

• E-4031: hERG Potassium Channel Blocker for 3D Cardiac Models

  2026-06-01

  E-4031 unlocks high-fidelity modeling of proarrhythmic risk in cutting-edge 3D cardiac organoid assays, enabling precise control of hERG potassium channel blockade. Its nanomolar potency and compatibility with advanced electrophysiological platforms make it an essential tool for pharmacological safety and mechanistic cardiac research.

• Berberrubine Modulates Lipid Metabolism and Gut Microbiota i

  2026-05-31

  This study demonstrates that berberrubine, a primary metabolite of berberine, alleviates non-alcoholic fatty liver disease (NAFLD) by regulating glucose and lipid metabolism and restoring gut microbiota composition in both in vivo and in vitro models. The findings highlight molecular targets and pathways relevant for translational research in hepatic steatosis and metabolic disease.

• SAR405: Precision Vps34 Inhibitor for Advanced Autophagy Ass

  2026-05-30

  SAR405 empowers targeted, reproducible autophagy inhibition and vesicle trafficking studies with nanomolar selectivity. This guide details practical workflows, troubleshooting tips, and protocol enhancements for leveraging SAR405 in disease modeling and mechanistic research.

445 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page